Biesterfeld, one of the leading international distributors of products and solutions in the world of specialty chemicals and ...

“To meet the growing demand and market opportunity, a pharma company must ensure it has the resources, capacity, and supply chain to grow ... facility in Denmark this century and will ...

The industrial robot market is facing a mixed picture over the coming years, with 2024 set to end on a challenging note.

Novo’s latest investment comes just days after the U.S. FTC greenlit the highly contentious acquisition of Catalent, which ...

Shortly after unveiling a $400 million upgrade at its campus in Hillerød, Denmark, Novo Nordisk is reinforcing its commitment ...

There is a pressing need for CDMOs to address these supply chain challenges in a volatile, uncertain, complex, and ambiguous (VUCA) environment, and to implement strategies for resilience in the face ...

Danish pharma giant Novo Nordisk will make a significant investment of approximately $1.2 billion to construct a new production facilit ...

There are many challenges in the pharmaceutical supply chain, from maintaining quality to security issues. Can blockchain provide the end-to-end visibility needed? It’s a good time for the ...

Novo Nordisk NOVO.B-3.89%decrease; red down pointing triangle plans to invest $1.2 billion in a new production site for rare-disease medicines in Denmark. The Danish pharmaceutical giant said it ...

Construction has already begun on the Ozempic-producer’s new Danish production facility and 40,000m² warehouse.